DETECTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK AND HEART FAILURE RISK

摘要

Methods are disclosed herein for determining the likelihood that a subject will develop atherosclerotic cardiovascular disease (ASCVD) or heart failure (HF). Methods are also disclosed for determining if a pharmaceutical agent is effective for the treatment or prevention of ASCVD or HF.